$22.99
$-1.02 (-4.44%)
End-of-day quote: 05/15/2024
NasdaqCM:BLFS
BioLife Solutions Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$143.27M | $161.76M | $119.16M | $48.09M | $27.37M | $19.74M | $11.02M | $8.23M | $6.45M | $6.19M | $8.95M | $5.66M | $2.76M | |
| GM % | Gross Margin % |
|
32.63% | 33.43% | 32.02% | 57.92% | 69.05% | 68.51% | 61.20% | 58.09% | 59.15% | 49.03% | 42.05% | 40.48% | 50.86% | |
| OM | Operating Margin |
|
-40.16% | -24.52% | -23.77% | -6.07% | 3.87% | 18.55% | -9.58% | -58.97% | -77.80% | -50.65% | -3.19% | -16.64% | -43.85% | |
| EPS | Earnings Per Share |
|
$0.00 | $-1.04 | $-0.69 | $-0.55 | $0.01 | $0.08 | $0.24 | $-0.13 | $-0.32 | $-0.35 | $-0.31 | $-0.22 | $-0.28 | $-0.42 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Sha. | Shares |
|
45.17m | 42.83m | 41.82m | 33.04m | 20.83m | 18.55m | 14.02m | 12.86m | 12.45m | 12.08m | 5.03m | 4.98m | 4.98m | |
| OCF | Operating Cash Flow |
|
$-12.50M | $-8.49M | $-4.59M | $6.65M | $1.21M | $2.35M | $0.61M | $-4.33M | $-4.97M | $-3.16M | $0.15M | $0.85M | $-0.99M | |
| FCF | Free Cash Flow |
|
$-48.78M | $-18.87M | $-12.98M | $4.72M | $0.54M | $1.85M | $-0.59M | $-4.47M | $-5.10M | $-3.75M | $-0.09M | $-0.30M | $-1.08M | |
| FCFS | Free Cash Flow Per Share |
|
$-0.54 | $-0.53 | $-0.50 | $-0.04 | $-0.06 | $0.09 | $0.03 | $-0.44 | $-0.52 | $-0.36 | $-0.02 | $-0.06 | $-0.22 |
